Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.
Clinical trial NCT04380688 · COMPLETED
Trial details
- NCT number
- NCT04380688
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-13
- Primary completion
- 2020-11-16
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.